MPP Strikes Landmark Licensing Deal With Novartis On Nilotinib

Agreement On Tasigna Generics Represents First Such Deal For A Cancer Medicine

Novartis has signed a voluntary licensing deal with the MPP for nilotinib • Source: Shutterstock